Endologix is a developer and manufacturer of minimally invasive aortic disorder treatments. The company’s focus is on endovascular stent grafts for treating abdominal aortic aneurysms (AAA), which are a weakening of the wall of the aorta – the body’s largest artery – resulting in a balloon-like enlargement. AAA continues to enlarge once it has developed, and it becomes increasingly susceptible to rupture if left untreated. Ruptured AAA is a leading cause of death in the United States. For more information, visit the company’s Web site: http://www.endologix.com
Let us hear your thoughts below: